- US12312352utility2025Use of a DPP-4 Inhibitor in SIRS And/or Sepsis0 cites
- US12312363utility2025Spiro[3h-indole-3,2′-pyrrolidin]-2(1h)-one Compounds and Derivatives as Mdm2-p53 Inhibitors0 cites
- US12312405utility2025Anti-pd-1 Antibodies0 cites
- US12281099utility2025Isoindolinone Substituted Indoles and Derivatives as RAS Inhibitors0 cites
- US12275722utility2025Process of Reworking a Crystalline Form of a Glycine Transport Inhibitor0 cites
- US12275798utility2025Tri-specific Binding Molecules0 cites
- US12263153utility2025Pharmaceutical Composition, Methods for Treating and Uses Thereof0 cites
- US12263157utility2025Aldosterone Synthase Inhibitors for Treating Chronic Kidney Disease0 cites
- US12257381utility2025System, Cartridge and Process0 cites
- US12240828utility2025Heteroaromatic Compounds as Vanin Inhibitors0 cites
- US12233068utility2025Combination of Active Agents for the Treatment of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)0 cites
- US12226411utility2025Soluble Guanylate Cyclase Activators for Treating Portal Hypertension0 cites
- US12213970utility2025Pyridinyl Sulfonamide Derivatives, Pharmaceutical Compositions and Uses Thereof0 cites
- US12195712utility2025Linked Perfusion to Continuous-flow Stirred-tank Reactor Cell Culture System0 cites
- US12187719utility2025Proteolysis Targeting Chimera (PROTACS) as Degraders of SMARCA2 and /or SMARCA40 cites
- US12178809utility2024Pyridinyl Sulfonamide Derivatives, Pharmaceutical Compositions and Uses Thereof0 cites
- US12178819utility2024DPP IV Inhibitor Formulations0 cites
- US12180223utility20243h,4h-thieno[2,3-d]pyrimidin-4-one Derivatives as TRPA1 Inhibitors0 cites
- US12171767utility2024Uses of DPP IV Inhibitors0 cites